# ALX Oncology Holdings Inc: Form SCHEDULE 13D/A, filed Feb 4, 2026

- Company: [ALX Oncology Holdings Inc](/companies/alxo.md) (CIK 1810182)
- Form: SCHEDULE 13D/A
- Filed: 2026-02-04
- Accepted by EDGAR: Feb 5, 2026, 02:03 ET
- Period: not reported
- Accession: 0000905148-26-000512
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1810182/000090514826000512/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1810182/000090514826000512/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1810182/000090514826000512/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 4, 2026.
Source: SEC EDGAR, the filing index for accession 0000905148-26-000512. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.